Medi caps Limited has officially declared to BSE that it does not qualify as a Large Corporate under SEBI's debt securities framework, exempting it from specific regulatory compliance requirements. The declaration was filed on April 8, 2026, addressing the non-applicability of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018.

Regulatory Compliance Declaration

The company formally notified BSE that it does not fall under the Large Corporate category as on March 31, 2026, as per the framework provided in the SEBI circular regarding fund raising by issuance of debt securities by large entities. This declaration means that the requirement of filing disclosures in the specified format under the aforementioned circular is not applicable to Medi-Caps Limited.

Financial Position Details

As part of the mandatory disclosure format, the company provided key financial information demonstrating its non-applicability status:

The company's zero outstanding borrowings as on March 31, 2026, clearly supports its position of not qualifying as a Large Corporate under the SEBI framework.

Regulatory Framework Reference

The declaration specifically references SEBI Operational circular SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021, and its update from April 13, 2022. The company confirmed that it does not meet the applicability criteria given under Chapter XII of this operational circular, which defines the parameters for Large Corporate classification.

Official Authorization

The filing was duly authorized and signed by key company officials:

• Abhishek Jain - Company Secretary & Compliance Officer (M. No. A36699)
• Hemant Sethi - Chief Financial Officer

Both officials digitally signed the declaration on April 8, 2026, ensuring proper corporate governance and compliance with filing requirements. The company has requested BSE to take the declaration on record, completing the necessary regulatory notification process.

Medi caps Limited has notified BSE about the Securities and Exchange Board of India's circular dated January 30, 2026, which introduces a special window for transfer and dematerialisation of physical securities. The circular, bearing reference number HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026, aims to ease investment processes for shareholders holding physical securities.

Special Window Details

The SEBI circular establishes a dedicated facility for securities that were sold or purchased prior to April 1, 2019. This special window will remain operational for one year, commencing from February 5, 2026, and concluding on February 4, 2027.

Eligibility and Coverage

The facility extends beyond new applications to include previously submitted transfer requests that faced issues. Specifically, the window covers transfer requests that were:

• Earlier submitted but rejected
• Returned due to documentation deficiencies
• Remained unattended due to procedural requirement gaps

Transfer Conditions and Lock-in Period

Under the new facility, transferred securities will be subject to specific conditions. All securities processed through this window will be mandatorily credited to the transferee only in dematerialised mode. Additionally, these securities will be placed under a lock-in period of one year from the date of registration of transfer.

During the lock-in period, the securities cannot be:

• Transferred to another party
• Lien marked
• Pledged for any purpose

Shareholder Action Required

Medi-Caps Limited has advised shareholders to take advantage of this opportunity by submitting the required documents mentioned in the SEBI circular. All documentation should be furnished to the company's Registrar and Share Transfer Agents, Ankit Consultancy Private Limited, located at 60, Electronic Complex, Pardeshipura, Indore (M.P.) 452010.

Shareholders can access the complete SEBI circular through the official SEBI website for detailed information about documentation requirements and procedural guidelines. For any queries related to this facility, shareholders are encouraged to contact the RTA or the company directly through the provided email addresses.